GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
1.440
-0.230 (-13.77%)
At close: Apr 3, 2025, 4:00 PM
1.330
-0.110 (-7.64%)
Pre-market: Apr 4, 2025, 6:33 AM EDT

GRI Bio Statistics

Total Valuation

GRI Bio has a market cap or net worth of $756,516. The enterprise value is -$4.15 million.

Market Cap 756,516
Enterprise Value -4.15M

Important Dates

The next estimated earnings date is Friday, May 9, 2025, before market open.

Earnings Date May 9, 2025
Ex-Dividend Date n/a

Share Statistics

GRI Bio has 525,358 shares outstanding.

Current Share Class 525,358
Shares Outstanding 525,358
Shares Change (YoY) n/a
Shares Change (QoQ) +164.06%
Owned by Insiders (%) 0.09%
Owned by Institutions (%) 2.48%
Float 524,755

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.19
P/TBV Ratio 0.19
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.43, with a Debt / Equity ratio of 0.03.

Current Ratio 3.43
Quick Ratio 3.07
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -382.52% and return on invested capital (ROIC) is -232.68%.

Return on Equity (ROE) -382.52%
Return on Assets (ROA) -118.39%
Return on Invested Capital (ROIC) -232.68%
Return on Capital Employed (ROCE) -200.71%
Revenue Per Employee n/a
Profits Per Employee -$2.53M
Employee Count 4
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -98.82% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -98.82%
50-Day Moving Average 7.53
200-Day Moving Average 13.14
Relative Strength Index (RSI) 20.81
Average Volume (20 Days) 795,570

Short Selling Information

The latest short interest is 19,433, so 3.70% of the outstanding shares have been sold short.

Short Interest 19,433
Short Previous Month 27,406
Short % of Shares Out 3.70%
Short % of Float 3.70%
Short Ratio (days to cover) 2.01

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -8.24M
Pretax Income -12.77M
Net Income -10.12M
EBITDA -8.23M
EBIT -8.24M
Earnings Per Share (EPS) -$55.21
Full Income Statement

Balance Sheet

The company has $5.03 million in cash and $119,000 in debt, giving a net cash position of $4.91 million or $9.34 per share.

Cash & Cash Equivalents 5.03M
Total Debt 119,000
Net Cash 4.91M
Net Cash Per Share $9.34
Equity (Book Value) 4.03M
Book Value Per Share 7.67
Working Capital 3.98M
Full Balance Sheet

Cash Flow

Operating Cash Flow -8.61M
Capital Expenditures n/a
Free Cash Flow -8.61M
FCF Per Share -$16.39
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GRI Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -1,337.45%
FCF Yield -1,138.24%

Analyst Forecast

The average price target for GRI Bio is $195.50, which is 13,476.39% higher than the current price. The consensus rating is "Strong Buy".

Price Target $195.50
Price Target Difference 13,476.39%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -44.28%
Stock Forecasts

Stock Splits

The last stock split was on February 24, 2025. It was a reverse split with a ratio of 0.0588235:1.

Last Split Date Feb 24, 2025
Split Type Reverse
Split Ratio 0.0588235:1

Scores

Altman Z-Score n/a
Piotroski F-Score 2